J.-J. Gonvers
University Hospital of Lausanne
35 Papers
540 Citations
J.-J. Gonvers is an academic researcher from University Hospital of Lausanne. The author has contributed to research in topics: Colonoscopy & Colorectal cancer. The author has an hindex of 20, co-authored 35 publications.
Chat about Author
Papers
Practice and complications of liver biopsy. Results of a nationwide survey in Switzerland.
TL;DR: This representative survey in Switzerland shows that the complication rate of liver biopsy is mainly related to the experience and training of the operator.
156
Appropriateness of colonoscopy in Europe (EPAGE II) Surveillance after polypectomy and after resection of colorectal cancer
Chantal Arditi,J.-J. Gonvers,Bernard Burnand,G. Minoli,D. Oertli,F. Lacaine,R. W. Dubois,John Paul Vader,S. Schusselé Filliettaz,Isabelle Peytremann-Bridevaux,Valérie Pittet,P. Juillerat,Florian Froehlich +12 more
TL;DR: Colonoscopy is recommended as a first-choice procedure for surveillance after polypectomy by all published guidelines and by the EPAGE II criteria, and the expert panel considered colonoscopy appropriate 1 year after resection.
Appropriateness of gastrointestinal endoscopy: risk of complications.
TL;DR: The balance between risks and benefits of gastrointestinal endoscopy for a given patient is essential in defining the appropriate use of endoscopic procedures, and true complication rates may be underestimated due to inconsistencies in the types of complications reported.
The European Panel on Appropriateness of Gastrointestinal Endoscopy (EPAGE): project and methods.
TL;DR: Upper and lower gastrointestinal endoscopies together now represent the most frequent procedures performed in the US health care system, totaling almost 5 000 000 proce.
62
Helicobacter pylori eradication treatment does not benefit patients with nonulcer dyspepsia.
Florian Froehlich,J.-J. Gonvers,Vincent Wietlisbach,Bernard Burnand,P. Hildebrand,C. Schneider,E. Saraga,Christoph Beglinger,John Paul Vader +8 more
TL;DR: This study adds further evidence that H. pylori is not the main pathogenetic or therapeutic target in patients with nonulcer dyspepsia, and shows no substantial benefit of curing H. Pylori infection in these patients.
62